clinical trial · NCT06872775
855303-RNA Biomarker Validation
Fractures, BoneBlood draws to assess RNA expression levels
brief summary
The purpose of this study is to test the accuracy of using RNA in blood as a way to forecast new fracture healing outcome.
started
Aug 25, 2025
primary completion
Aug 24, 2028
completion
Aug 24, 2028
last updated
Jan 16, 2026
detailed description
This study will follow a registry + biospecimen collection format. Subjects will be enrolled at participating Sites as they present for care for new traumatic appendicular skeletal fractures (0 - ≤7 Days post-injury) and will provide blood specimens for study analysis and future use at up to 4 post-injury windows of treatment (i.e., Window 1, 0 - ≤7 Days; Window 2, 8 - ≤14 days; Window 3, 15 - ≤42 Days; and Window 4, 43 - ≤84 Days post-injury).
official title
A Multi-Center Observational Study to Validate RNA-Biomarkers as Prognostic of Fracture Healing
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol